Skip to main content

Find Clinical Trials

Home
Conditions
Mastocytosis

Clinical trial condition

Mastocytosis

Explore clinical trials studying Mastocytosis. Study availability and eligibility vary by location and protocol.

37 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Mastocytosis trial results

Completed

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

NCT00814073

Conditions: Albinism, Amino Acid Metabolism, Inborn Errors, Behavior, +28 more
Locations: UC Davis Health System , Department of Dermatology Sacramento, California, United States

MD Anderson Cancer Centre Houston, Texas, United States

CHU d'Amiens Amiens, France

Hôpital Avicenne Bobigny, France

View all 24 locations

View Trial Details

Completed

The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy

NCT02503800

Conditions: Bites and Stings, Chemically-Induced Disorders, Hypersensitivity, +11 more
Locations: Meir Medical Center Kfar Saba, Israel

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002

NCT02808793

Conditions: Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +6 more
Locations: Charité - Universitätsmedizin Berlin Berlin, Germany

View Trial Details

Completed

Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis

NCT00831974

Conditions: Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +4 more
Locations: Not specified

View Trial Details

Completed

Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation

NCT01266369

Conditions: Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +4 more
Locations: Not specified

View Trial Details

Completed

Stem Cell Transplantation to Treat Systemic Mastocytosis

NCT00006413

Conditions: Graft vs Host Disease, Immune System Diseases, Mast Cell Activation Disorders, +5 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

NCT00154388

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
Locations: Not specified

View Trial Details

Completed

Molecular Mechanisms and Diagnosis of Mastocytosis

NCT00336076

Conditions: Albinism, Amino Acid Metabolism, Inborn Errors, Anaphylaxis, +21 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Study on Mastocytosis for Rupatadine Treatment

NCT01481909

Conditions: Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +4 more
Locations: University Charité Berlin, Germany

View Trial Details

Completed

Treatment of Indolent Systemic Mastocytosis With PA101

NCT02478957

Conditions: Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +7 more
Locations: Hopital Necker - Enfants Malades Paris, France

Charité - Universitätsmedizin Berlin Berlin, Germany

Klinikum Darmstadt Darmstadt, Germany

University Medical Center Mainz Mainz, Germany

View Trial Details